Cornerstone Capital Management Holdings’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio CNCE Stock Details CNCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-3,600	Closed	-$36K	–	1442
2016 Q3	$36K	Sell	3,600 -1,400	-28%	-$15.3K	﹤0.01%	1305
2016 Q2	$56K	Hold	5,000	–	–	﹤0.01%	1310
2016 Q1	$68K	Sell	5,000 -4,300	-46%	-$61.9K	﹤0.01%	1362
2015 Q4	$176K	Buy	9,300 +1,800	+24%	+$39.1K	﹤0.01%	1228
2015 Q3	$141K	Buy	+7,500	New	+$127K	﹤0.01%	1279

Other funds holding CNCE

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

SAM

Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return

Cornerstone Capital Management Holdings's CNCE Position: Q4 2016 in Review

Cornerstone Capital Management Holdings sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q4 2016, closing a stake of 3,600 shares — an estimated $36K sold.

Cornerstone Capital Management Holdings first reported a position in CNCE in Q3 2015 and held it in 5 quarters. The position peaked at $176K in Q4 2015. 89 funds tracked by Wall St. Rank hold CNCE as of Q4 2016.

Cornerstone Capital Management Holdings reported no remaining Concert Pharmaceuticals, Inc. position as of Q4 2016 after selling out during the quarter.
Cornerstone Capital Management Holdings sold 3,600 Concert Pharmaceuticals, Inc. shares in Q4 2016, an estimated $36K.
Cornerstone Capital Management Holdings first reported a position in Concert Pharmaceuticals, Inc. in Q3 2015 and held it in 5 quarters.
Cornerstone Capital Management Holdings's Concert Pharmaceuticals, Inc. position peaked at $176K in Q4 2015.
89 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q4 2016.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2016, filed 14 Feb 2017.